Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMC 2074699)

Published in Br J Cancer on September 01, 1996


A Håkansson1, B Gustafsson, L Krysander, L Håkansson

Author Affiliations

1: Department of Oncology, University Hospital, Linköping, Sweden.

Articles citing this

Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma. Cancer Res (2012) 2.48

Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management. Scientifica (Cairo) (2013) 1.28

Oncogene MYCN regulates localization of NKT cells to the site of disease in neuroblastoma. J Clin Invest (2007) 1.28

Antiproliferative Properties of Type I and Type II Interferon. Pharmaceuticals (Basel) (2010) 1.22

Releasing the brake on the immune system: ipilimumab in melanoma and other tumors. Cancer Biother Radiopharm (2010) 1.22

Intratumoural and peripheral blood lymphocyte subsets in patients with metastatic renal cell carcinoma undergoing interleukin-2 based immunotherapy: association to objective response and survival. Br J Cancer (2002) 1.00

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. Br J Cancer (2003) 0.92

Clinical and immunologic basis of interferon therapy in melanoma. Ann N Y Acad Sci (2009) 0.92

The prognostic role of the preoperative absolute lymphocyte count and absolute monocyte count in patients with resected advanced melanoma. Am J Clin Oncol (2015) 0.85

Recent advances in the development of breast cancer vaccines. Breast Cancer (Dove Med Press) (2014) 0.85

Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes. Br J Cancer (2001) 0.84

Pro-Inflammatory Cytokines Predict Relapse-Free Survival after One Month of Interferon-α but Not Observation in Intermediate Risk Melanoma Patients. PLoS One (2015) 0.78

Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas. Neuro Oncol (2017) 0.77

Biological response modifiers in cancer. MedGenMed (2006) 0.76

Impact of age on the management of primary melanoma patients. Oncology (2013) 0.75

Articles cited by this

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report. N Engl J Med (1988) 8.90

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science (1986) 8.07

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94

Tumor thickness and lymphocytic infiltration in malignant melanoma of the head and neck. Am J Surg (1974) 2.33

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes. J Immunol (1986) 1.74

Lysis of autologous melanoma cells by tumor-infiltrating lymphocytes: association with clinical response. J Natl Cancer Inst (1991) 1.46

Spontaneous regression of melanoma. Pathology (1975) 1.42

Human tumor-infiltrating lymphocytes: a marker of host response. Semin Hematol (1985) 1.38

Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst (1981) 1.30

Immunocytochemical analysis of the cellular infiltrate in primary regressing and non-regressing malignant melanoma. J Invest Dermatol (1991) 1.22

Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma. J Immunol (1982) 1.21

Biologic effects of interferons. J Invest Dermatol (1990) 1.20

Interferons. Lancet (1989) 1.18

Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi. Cancer Res (1983) 1.17

Thin malignant melanomas with regression and metastases. Arch Dermatol (1987) 1.16

Current therapy for malignant melanoma. Semin Oncol (1989) 1.13

Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Cancer Res (1988) 1.07

Differential immune reactivity of tumour-intrinsic and peripheral-blood lymphocytes against autoplastic colorectal carcinoma cells. Br J Cancer (1981) 1.03

Histologic regression in malignant melanoma: an interobserver concordance study. J Cutan Pathol (1993) 0.97

In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin. Clin Exp Immunol (1983) 0.95

Partial regression in thin primary cutaneous malignant melanomas clinical stage I. A study of 486 cases. Virchows Arch A Pathol Anat Histopathol (1985) 0.92

Immunologic effects of interferon. J Invest Dermatol (1990) 0.90

A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis. Acta Pathol Microbiol Scand A (1978) 0.88

Spontaneous regression of metastatic melanoma. Ann Plast Surg (1991) 0.88

Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy. Crit Rev Oncol Hematol (1992) 0.87

Recombinant interferons in the management of advanced malignant melanoma. Updated review of five prospective clinical trials and long-term responders. Am J Clin Oncol (1988) 0.81

Articles by these authors

A transient outward current in a mammalian central neurone blocked by 4-aminopyridine. Nature (1982) 2.94

Relation between shapes of post-synaptic potentials and changes in firing probability of cat motoneurones. J Physiol (1983) 2.92

A stellar relic from the early Milky Way. Nature (2002) 2.56

Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia (2007) 2.35

Long-term potentiation in the hippocampus using depolarizing current pulses as the conditioning stimulus to single volley synaptic potentials. J Neurosci (1987) 2.30

A probable stellar solution to the cosmological lithium discrepancy. Nature (2006) 2.28

Direct and indirect activation of nerve cells by electrical pulses applied extracellularly. J Physiol (1976) 2.03

Facilitated induction of hippocampal long-lasting potentiation during blockade of inhibition. Nature (1983) 1.99

Mutations in the BRAF and N-ras genes in childhood acute lymphoblastic leukaemia. Leukemia (2005) 1.95

Influence of stretch-evoked synaptic potentials on firing probability of cat spinal motoneurones. J Physiol (1984) 1.89

Structural studies of the Vibrio cholerae O-antigen. Carbohydr Res (1982) 1.78

Firing behaviour of a neurone model based on the afterhyperpolarization conductance time course and algebraical summation. Adaptation and steady state firing. Acta Physiol Scand (1974) 1.71

Autophagy, organelles and ageing. J Pathol (2007) 1.64

Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest (1980) 1.56

Monoclonal antibodies against Vibrio cholerae lipopolysaccharide. Infect Immun (1982) 1.55

Plasma exudation as a first line respiratory mucosal defence. Clin Exp Allergy (1991) 1.52

Evidence for two types of afterhyperpolarization in CA1 pyramidal cells in the hippocampus. Brain Res (1981) 1.48

Regulation of the release of eosinophil cationic protein by eosinophil adhesion. Clin Exp Allergy (2000) 1.48

Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology (2000) 1.44

Quantal variability at glutamatergic synapses in area CA1 of the rat neonatal hippocampus. J Physiol (2001) 1.42

Firing behaviour of a neurone model based on the afterhyperpolarization conductance time course. First interval firing. Acta Physiol Scand (1974) 1.39

Afterhyperpolarization conductance time course in lumbar motoneurones of the cat. Acta Physiol Scand (1974) 1.37

Facilitation of hippocampal long-lasting potentiation by GABA antagonists. Acta Physiol Scand (1985) 1.36

Postsynaptic control of hippocampal long-term potentiation. J Physiol (Paris) (1986) 1.35

Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin. Immunology (1995) 1.30

Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer (2000) 1.30

Relations among passive electrical properties of lumbar alpha-motoneurones of the cat. J Physiol (1984) 1.28

Long-term potentiation involves enhanced synaptic excitation relative to synaptic inhibition in guinea-pig hippocampus. J Physiol (1987) 1.27

Kinetic studies of phagocytosis. I. The serum independent particle uptake by PMN from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum (1978) 1.24

Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg (1996) 1.24

Regulation of repetitive firing in motoneurones by the afterhyperpolarization conductance. Brain Res (1971) 1.22

An investigation of threshold properties among cat spinal alpha-motoneurones. J Physiol (1984) 1.21

Immunisation of metastatic cancer patients with MAGE-3 protein combined with adjuvant SBAS-2: a clinical report. Eur J Cancer (2003) 1.21

Hippocampal long-term potentiation is induced by pairing single afferent volleys with intracellularly injected depolarizing current pulses. Acta Physiol Scand (1986) 1.21

Hippocampal long-lasting potentiation produced by pairing single volleys and brief conditioning tetani evoked in separate afferents. J Neurosci (1986) 1.21

Saturating summation of the afterhyperpolarization conductance in spinal motoneurones: a mechanism for 'secondary range' repetitive firing. Brain Res (1978) 1.19

Vesicle release probability and pre-primed pool at glutamatergic synapses in area CA1 of the rat neonatal hippocampus. J Physiol (2001) 1.18

Neutrophils from term and preterm newborn infants express the high affinity Fcgamma-receptor I (CD64) during bacterial infections. Pediatr Res (1999) 1.16

Lysosomal labilization. IUBMB Life (2006) 1.16

Studies on the phagocytic activity of the granulocytes in psoriasis and palmoplantar pustulosis. Br J Dermatol (1983) 1.11

Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine (2013) 1.10

Identification of IL-5 and RANTES as the major eosinophil chemoattractants in the asthmatic lung. J Allergy Clin Immunol (1996) 1.09

Immunological characterization of Vibrio cholerae O:1 lipopolysaccharide, O-side chain, and core with monoclonal antibodies. Infect Immun (1985) 1.09

Respiratory distress syndrome and thrombotic, non-bacterial endocarditis after amitriptyline overdose. Acta Med Scand (1977) 1.09

Changes in field excitatory postsynaptic potential shape induced by tetanization in the CA1 region of the guinea-pig hippocampal slice. Neuroscience (1990) 1.08

Psoralens used for cosmetic sun tanning: an unusual cause of extensive burn injury. Burns (1996) 1.08

Firing behaviour of dorsal spinocerebellar tract neurones. J Physiol (1978) 1.08

A possible correlate of the postsynaptic condition for long-lasting potentiation in the guinea pig hippocampus in vitro. Neurosci Lett (1984) 1.07

Effect of hyaluronic acid on phagocytosis of opsonized latex particles. Scand J Immunol (1980) 1.07

Large long-lasting potentiation in the dentate gyrus in vitro during blockade of inhibition. Brain Res (1983) 1.05

Ionotropic glutamate receptors. Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol (1996) 1.05

Changes in motoneurone electrical properties following axotomy. J Physiol (1979) 1.05

Monoclonal antibodies against group- and type-specific lipopolysaccharide antigens of Vibrio cholerae O:1. J Clin Microbiol (1983) 1.05

Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy. Am J Reprod Immunol (1996) 1.05

Blood eosinophil number and activity in relation to lung function in patients with asthma and with eosinophilia. J Allergy Clin Immunol (1991) 1.03

Physiological mechanisms underlying long-term potentiation. Trends Neurosci (1988) 1.02

Improving the efficacy of cancer immunotherapy. Eur J Cancer (2009) 1.01

Paired-pulse plasticity at the single release site level: an experimental and computational study. J Neurosci (2001) 1.01

Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fc gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol (1999) 1.01

Therapist-assisted versus self-help relaxation treatment of chronic headaches in adolescents: a school-based intervention. J Child Psychol Psychiatry (1987) 1.01

Factors explaining heterogeneity in short-term synaptic dynamics of hippocampal glutamatergic synapses in the neonatal rat. J Physiol (2001) 1.01

On the presence within tumours of clones that differ in sensitivity to cytostatic drugs. Acta Pathol Microbiol Scand A (1974) 1.01

On long-lasting potentiation in the hippocampus: a proposed mechanism for its dependence on coincident pre- and postsynaptic activity. Acta Physiol Scand (1985) 1.00

Improved renal function after early conversion from a calcineurin inhibitor to everolimus: a randomized trial in kidney transplantation. Am J Transplant (2012) 1.00

A synaptic potential following single volleys in the hippocampal CA1 region possibly involved in the induction of long-lasting potentiation. Acta Physiol Scand (1985) 0.99

Kinetic studies of neutrophil phagocytosis. V. studies on the co-operation between the Fc and C3b receptors. Immunology (1982) 0.99

Airway permeability. Clin Exp Allergy (1995) 0.99

Expression of laminins in the airways in various types of asthmatic patients: a morphometric study. Am J Respir Cell Mol Biol (1996) 0.98

Eosinophil activation in allergic disease. Int Arch Allergy Appl Immunol (1987) 0.98

Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscul Disord (2002) 0.97

Electrophoretic and immunochemical studies of Micrurus snake venoms. Toxicon (1994) 0.97

Dysphagia and its consequences in the elderly. Dysphagia (1991) 0.97

Effects of axotomy on the distribution of passive electrical properties of cat motoneurones. J Physiol (1984) 0.96

Detection of the response regulator AgrA in the cytosolic fraction of Staphylococcus aureus by monoclonal antibodies. FEMS Microbiol Lett (1996) 0.96

Leucocyte adhesion protein deficiency in Irish setter dogs. Vet Immunol Immunopathol (1992) 0.95

Subepithelial hydrostatic pressure may regulate plasma exudation across the mucosa. Int Arch Allergy Appl Immunol (1990) 0.95

Effect of repetitive activation on the afterhyperpolarization in dorsal spinocerebellar tract neurones. J Physiol (1978) 0.95

Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies. Eur J Clin Microbiol (1985) 0.94

Oral N-acetylcysteine reduces selected humoral markers of inflammatory cell activity in BAL fluid from healthy smokers: correlation to effects on cellular variables. Eur Respir J (1988) 0.94

Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol (1996) 0.94

On the direct Fourier method for computer tomography. IEEE Trans Med Imaging (2000) 0.94

On re-excitation of feline motoneurones: its mechanism and consequences. J Physiol (1984) 0.94

Effects of chronic partial deafferentiation on the electrical properties of lumbar alpha-motoneurones in the cat. Brain Res (1982) 0.93

The combined action of hyaluronic acid and fibronectin stimulates neutrophil migration. J Immunol (1985) 0.93

Developmental changes in release properties of the CA3-CA1 glutamate synapse in rat hippocampus. J Neurophysiol (2004) 0.93

Correlations of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer (1996) 0.93

Effect of microspheres in intra-arterial chemotherapy. A study of arterio-venous shunting and passage of a labelled marker. Med Oncol Tumor Pharmacother (1987) 0.93

Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group. Cancer (1996) 0.93

On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. Br J Cancer (2003) 0.92

Time course and potential dependence of the membrane conductance change during the afterhyperpolarization in the cat's alpha-motoneurones. Brain Res (1970) 0.91

GM1 ganglioside enzyme-linked immunosorbent assay for detection of heat-labile enterotoxin produced by human and porcine Escherichia coli strains. J Clin Microbiol (1982) 0.90

Hyperpolarization following long-lasting tetanic activation of hippocampal pyramidal cells. Brain Res (1983) 0.90

Intrathecal sufentanil compared with epidural bupivacaine analgesia in labour. Eur J Anaesthesiol (1997) 0.90

A new injection portal for brachially inserted central venous catheter. A multicenter study. Med Oncol Tumor Pharmacother (1990) 0.90

Glutathione in bronchoalveolar lavage fluid from smokers is related to humoral markers of inflammatory cell activity. Inflammation (1989) 0.90

Excretion of paracetamol in human breast milk. Eur J Clin Pharmacol (1981) 0.90

Unsaturated lipids and intestinal bacteria as sources of endogenous production of ethene and ethylene oxide. Carcinogenesis (1989) 0.89

Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. J Allergy Clin Immunol (1992) 0.89